Loading...
Targeting CD44 Augments the Efficacy of Tregs in Autoimmune Diabetes
Curing type 1 diabetes (T1D) will require lasting control of the autoimmune response that destroys insulin-producing islet β-cells. Re-establishing tolerance by restoring/replacing Tregs has significant potential for treatment of T1D but will require strategies to augment and maintain their efficacy...
Na minha lista:
| Udgivet i: | Immunol Lett |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4323628/ https://ncbi.nlm.nih.gov/pubmed/25447401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.imlet.2014.10.002 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|